Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | HPGD | P15428 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 5/20 | 0.60 |
| ▸ | TP53 | P04637 | 4/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.47 |
| ▸ | PRKCI | P41743 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3062926 | 0.81 | MAPT (0.58) | ALDH1A1HPGDLMNATSHRMAPT | |
| SCHEMBL15065374 | 0.77 | MAPT (0.55) | ALDH1A1HPGDLMNATSHRMAPT | |
| SCHEMBL3076538 | 0.75 | SMN1; SMN2 (0.56) | ALDH1A1HPGDLMNAMAPTTP53 | |
| SCHEMBL3082154 | 0.72 | MAPT (0.68) | ALDH1A1HPGDLMNATSHRMAPT | |
| SCHEMBL8512161 | 0.70 | ALDH1A1 (0.47) | ALDH1A1HPGDLMNATSHRMAPT | |
| SCHEMBL8514102 | 0.70 | MAPT (0.60) | ALDH1A1HPGDLMNATSHRMAPT | |
| SCHEMBL3084617 | 0.69 | MAPT (0.80) | ALDH1A1HPGDLMNATSHRMAPT | |
| SCHEMBL3075331 | 0.69 | ALDH1A1 (0.59) | ALDH1A1HPGDLMNATSHRMAPT | |
| SCHEMBL24648643 | 0.69 | RAB9A (0.55) | ALDH1A1HPGDLMNAMAPTALOX15 | |
| SCHEMBL21533600 | 0.68 | ADRB1 (0.65) | ALDH1A1LMNAMAPTTP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100261708-A1 | Diazepane Compounds Which Modulate The CB2 Receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261708-A1 | Diazepane Compounds Which Modulate The CB2 Receptor | CNR1, CNR2, BDKRB2 | ALDH1A1 2369/4885HPGD 781/4885LMNA 4272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.